Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

KNK-437: a novel inhibitor of the development of thermotolerance and HSP induction in cancer cells

July 5, 2000

Inhibitors of dual-specificity phosphatases inhibit growth of breast cancer cells

July 5, 2000

Cell Pathways reports positive one-year extension data from phase III Aptosyn study

July 5, 2000

Theratechnologies moves forward with PDT development program

July 5, 2000

Myriad Genetics to use investment funds for colon cancer research

July 5, 2000

Incyte and Baylor collaborate on genomic cancer research in children

July 5, 2000

Clinical trials of cancer gene therapy begin at Cobra Therapeutics

July 5, 2000

Prolifix enters agreement for cell cycle protein research

July 4, 2000

New human prolactin receptor antagonist S179D-PRL undergoes extensive biological testing

July 4, 2000

CPMP recommends approval of Caelyx for treatment of advanced ovarian cancer

July 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...